Refana

corporate RELATIONS

  • Home
  • Programs
    • AI in Medicine
    • Vaccines
    • Early Cancer Detection
  • Corporate
  • Team
  • About
  • Blog
    • News
    • COVID Industry Updates

Mark and Glenn Turchan are early investors in Refana, a company on the leading-edge of vaccine technology

Picture
Read their story
'No one is safe until everyone is safe'

​Tedros Adhanom Ghebreyesus
​WHO Director General

corporate relations

For further information please contact:
Mark Turchan

mark turchan

Corporate Relations Americas
​mpturchan@gmail.com
Tom Barry

tom barry

Corporate Relations EMEA
tom.barry@capriam.com
Shape Divider - Style split
​Practical Solutions for complex and ​urgent global medical problems

HOME     |     PROGRAMS    |    TEAM     |     ABOUT     |     NEWS
Privacy Policy | Cookie Policy
© 2023 Refana Inc
  • Home
  • Programs
    • AI in Medicine
    • Vaccines
    • Early Cancer Detection
  • Corporate
  • Team
  • About
  • Blog
    • News
    • COVID Industry Updates